BioNexus Gene Lab (BGLC) EBT Margin (2018 - 2026)
BioNexus Gene Lab (BGLC) posted EBT Margin of 2379.72% for Q1 2026, down 1011.08% sequentially from 214.18% in Q4 2025, and down 235055.0% YoY from N/an in Q1 2025.
BioNexus Gene Lab (BGLC) EBT Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has reported EBT Margin for 9 years, with the latest figure at 2379.72% in Q1 2026.
- Quarterly EBT Margin fell 235055.0% year-over-year to 2379.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 54.7% (down 3166.0% YoY) and the FY2025 annual result came in at 40.2%, down 2343.0% from the prior year.
- EBT Margin slipped to 2379.72% in Q1 2026 per BGLC's latest filing, from 214.18% in the prior quarter.
- Over five years, EBT Margin peaked at 12.9% in Q2 2024 and troughed at 2379.72% in Q1 2026.
- A 5-year average of 167.61% and a median of 10.72% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2026: EBT Margin surged 4809 bps in 2024, then sank 235055 bps in 2026.
- Over 5 years, EBT Margin stood at 4.49% in 2022, then jumped by 349 bps to 11.16% in 2023, then slumped by 250 bps to 16.72% in 2024, then sank by 1181 bps to 214.18% in 2025, then sank by 1011 bps to 2379.72% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 2379.72%, 214.18%, and 27.87% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn | 27.41% |
| 2 | Sherwin Williams | 84.58 Bn | 84.29 Bn | 3.34 Bn | 16.39% |
| 3 | Ecolab | 78.46 Bn | 73.33 Bn | 1.95 Bn | 15.71% |
| 4 | Air Products & Chemicals | 68.28 Bn | 67.30 Bn | 1.04 Bn | -61.30% |
| 5 | Ppg Industries | 25.32 Bn | 23.72 Bn | 1.81 Bn | 12.66% |
| 6 | Chemical & Mining Co Of Chile | 23.50 Bn | 19.63 Bn | 778.60 Mn | 39.02% |
| 7 | LyondellBasell Industries | 22.00 Bn | 19.37 Bn | 2.04 Bn | 8.80% |
| 8 | International Flavors & Fragrances | 21.40 Bn | 20.84 Bn | 853.00 Mn | 3.28% |
| 9 | DuPont de Nemours | 18.89 Bn | 17.15 Bn | 639.00 Mn | 14.62% |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | -376.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,379.72% |
| Dec 31, 2025 | -214.18% |
| Sep 30, 2025 | -27.87% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | -29.17% |
| Dec 31, 2024 | -16.72% |
| Sep 30, 2024 | -51.09% |
| Jun 30, 2024 | 12.90% |
| Mar 31, 2024 | -3.51% |
| Dec 31, 2023 | 11.16% |
| Sep 30, 2023 | -99.18% |
| Jun 30, 2023 | -10.72% |
| Mar 31, 2023 | -2.23% |
| Dec 31, 2022 | -4.49% |
| Sep 30, 2022 | -2.61% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | 1.04% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 10.36% |
| Jun 30, 2021 | 4.42% |